These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37345074)

  • 1. Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma.
    Huynh KN; Rao S; Roth B; Bryan T; Fernando DM; Dayyani F; Imagawa D; Abi-Jaoudeh N
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
    Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
    Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.
    Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression.
    Chen Y; Li H; Chen D; Jiang X; Wang W; Li D; Shan H
    Dig Dis Sci; 2022 Aug; 67(8):3806-3816. PubMed ID: 34383201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors.
    Chen C; Wang J; Liu R; Qian S
    Tumour Biol; 2012 Aug; 33(4):1095-103. PubMed ID: 22407533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense hypoxia-inducible factor-1alpha augments transcatheter arterial embolization in the treatment of hepatocellular carcinomas in rats.
    Sun X; Jiang H; Jiang X; Tan H; Meng Q; Sun B; Xu R; Krissansen GW
    Hum Gene Ther; 2009 Apr; 20(4):314-24. PubMed ID: 19327024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
    Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
    World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells.
    Matsufuji S; Kitajima Y; Higure K; Kimura N; Maeda S; Yamada K; Ito K; Tanaka T; Kai K; Noshiro H
    Cancer Metab; 2023 Dec; 11(1):25. PubMed ID: 38066600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting HIF-1α and VEGF by lentivirus-mediated RNA interference reduces liver tumor cells migration and invasion under hypoxic conditions.
    Chen J; Lai L; Liu S; Zhou C; Wu C; Huang M; Lin Q
    Neoplasma; 2016; 63(6):934-940. PubMed ID: 27565331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model.
    Liang B; Zheng CS; Feng GS; Wu HP; Wang Y; Zhao H; Qian J; Liang HM
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):806-12. PubMed ID: 19937023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
    Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
    Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
    Lin ZH; Jiang JR; Ma XK; Chen J; Li HP; Li X; Wu XY; Huang MS; Lin Q
    Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
    Lin D; Wu J
    World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Wang Z; Li Q; Liang B
    Pharmaceuticals (Basel); 2024 Aug; 17(8):. PubMed ID: 39204162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo.
    Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J
    Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
    Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
    Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.